» Articles » PMID: 17822691

Cartilage Link Protein 1 (Crtl1), an Extracellular Matrix Component Playing an Important Role in Heart Development

Abstract

To expand our insight into cardiac development, a comparative DNA microarray analysis was performed using tissues from the atrioventricular junction (AVJ) and ventricular chambers of mouse hearts at embryonic day (ED) 10.5-11.0. This comparison revealed differential expression of approximately 200 genes, including cartilage link protein 1 (Crtl1). Crtl1 stabilizes the interaction between hyaluronan (HA) and versican, two extracellular matrix components essential for cardiac development. Immunohistochemical studies showed that, initially, Crtl1, versican, and HA are co-expressed in the endocardial lining of the heart, and in the endocardially derived mesenchyme of the AVJ and outflow tract (OFT). At later stages, this co-expression becomes restricted to discrete populations of endocardially derived mesenchyme. Histological analysis of the Crtl1-deficient mouse revealed a spectrum of cardiac malformations, including AV septal and myocardial defects, while expression studies showed a significant reduction in versican levels. Subsequent analysis of the hdf mouse, which carries an insertional mutation in the versican gene (CSPG2), demonstrated that haploinsufficient versican mice display septal defects resembling those seen in Crtl1(-/-) embryos, suggesting that reduced versican expression may contribute to a subset of the cardiac abnormalities observed in the Crtl1(-/-) mouse. Combined, these findings establish an important role for Crtl1 in heart development.

Citing Articles

Combined genetic-pharmacologic inactivation of tightly linked ADAMTS proteases in temporally specific windows uncovers distinct roles for versican proteolysis and glypican-6 in cardiac development.

Mead T, Bhutada S, Foulcer S, Peruzzi N, Nelson C, Seifert D Matrix Biol. 2024; 131:1-16.

PMID: 38750698 PMC: 11526477. DOI: 10.1016/j.matbio.2024.05.003.


Hapln1 promotes dedifferentiation and proliferation of iPSC-derived cardiomyocytes by promoting versican-based GDF11 trapping.

Hao D, Qin Y, Zhou S, Dong B, Yang J, Zou P J Pharm Anal. 2024; 14(3):335-347.

PMID: 38618242 PMC: 11010450. DOI: 10.1016/j.jpha.2023.09.013.


HAPLN1 knockdown inhibits heart failure development via activating the PKA signaling pathway.

Yan T, Song S, Sun W, Ge Y BMC Cardiovasc Disord. 2024; 24(1):197.

PMID: 38580957 PMC: 10996236. DOI: 10.1186/s12872-024-03861-8.


The Current State of Extracellular Matrix Therapy for Ischemic Heart Disease.

Hamsho K, Broadwin M, Stone C, Sellke F, Abid M Med Sci (Basel). 2024; 12(1).

PMID: 38390858 PMC: 10885030. DOI: 10.3390/medsci12010008.


Are There Hopeful Therapeutic Strategies to Regenerate the Infarcted Hearts?.

Oh G, Choi Y, Park B, Ban K, Park H Korean Circ J. 2023; 53(6):367-386.

PMID: 37271744 PMC: 10244183. DOI: 10.4070/kcj.2023.0098.


References
1.
Waller 3rd B, Wessels A . Cardiac morphogenesis and dysmorphogenesis. An immunohistochemical approach. Methods Mol Biol. 2000; 135:151-61. DOI: 10.1385/1-59259-685-1:151. View

2.
Watanabe H, Yamada Y . Mice lacking link protein develop dwarfism and craniofacial abnormalities. Nat Genet. 1999; 21(2):225-9. DOI: 10.1038/6016. View

3.
Liu H, McKenna L, Dean M . An N-terminal peptide from link protein can stimulate biosynthesis of collagen by human articular cartilage. Arch Biochem Biophys. 2000; 378(1):116-22. DOI: 10.1006/abbi.2000.1758. View

4.
Schroeder J, Jackson L, Lee D, Camenisch T . Form and function of developing heart valves: coordination by extracellular matrix and growth factor signaling. J Mol Med (Berl). 2003; 81(7):392-403. DOI: 10.1007/s00109-003-0456-5. View

5.
Keyes W, Logan C, Parker E, Sanders E . Expression and function of bone morphogenetic proteins in the development of the embryonic endocardial cushions. Anat Embryol (Berl). 2003; 207(2):135-47. DOI: 10.1007/s00429-003-0337-2. View